EOD vs WNEB

The deterministic health profile is severely compromised with a Piotroski F-Score of 1/9, indicating critical weakness in traditional financial health metrics. However, this is contrasted by a strong valuation profile, with the current price of $6.31 trading at a significant discount to its intrinsic value of $9.87 and a very low P/E of 4.48. While long-term price performance is robust (5Y +85.8%), the current technical trend is heavily bearish (10/100). The asset functions as a high-yield income vehicle rather than a growth company, making traditional corporate health scores misleading but mandatory for this risk assessment.

WNEB presents a classic value-growth paradox: the company shows strong earnings growth (56.7% YoY) and trades below both its Graham Number ($14.38) and Intrinsic Value ($22.12), yet it is plagued by bearish technicals and insider sentiment. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the low ROE (6.31%) suggests inefficient capital utilization. While the valuation is attractive, the heavy concentration in Commercial Real Estate (CRE) and a Technical Trend score of 10/100 suggest significant near-term headwinds.